Latest Biotech Startup Funding Rounds

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

Clinical-stage bioresorbable implants designed to support natural breast-tissue regeneration and mark the tumour bed after lumpectomy.

A biotechnology company developing an oral drug candidate for dry mouth and related gland-function disorders.

Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders.

Doroth develops lab-on-a-chip molecular tests and monitoring services that help agricultural businesses detect plant pathogens and track biological crop treatments closer to where decisions are made.

DataHow builds DataHowLab, a process-modeling and digital-twin platform for biopharmaceutical process engineers and manufacturers.

NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury.

Amyl Therapeutics is developing immunotherapies that target amyloid aggregates linked to neurodegenerative disease.

IntraGel Therapeutics develops SRGel, a solvent-free injectable formulation designed to release drugs gradually from a single administration.

Senticell is developing a liquid-biopsy diagnostic based on nucleic acids associated with red blood cells.